Home
Prosight Management reported a 5.3% stake in Janux Therapeutics JANX · 3,157,220 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 5.3%
- Last report
- First report
- Shares held
- 3,157,220 sh
- Class
- Common Stock, $0.001 par value per share
- Holder
- Prosight Management
- Event date
- 26/02/03
- Filed
- 26/02/06
First 5%+ report · 5.3% stake
Janux Therapeutics trades, last 26 weeks
What else happened in Janux Therapeutics around then
Filed or reported within 30 days of the trade day · 01/04~03/05Prosight Management's other 5% stake reports
- Prosight Management
5% stakeOnKure Therapeutics
5% stakeOnKure Therapeutics
OKUR
2.4% stake
978,992 sh
2.4% stake
Filed 08/10
- Prosight Management
5% stakeMeiraGTx Holdings
5% stakeMeiraGTx Holdings
MGTX
4% stake
3,211,788 sh
4% stake
Filed 02/13
- Prosight Management
5% stakeADC Therapeutics
5% stakeADC Therapeutics
ADCT
6.8% stake
8,477,338 sh
6.8% stake
Filed 02/13
- Prosight Management
5% stakeOnKure Therapeutics
5% stakeOnKure Therapeutics
OKUR
5.8% stake
745,649 sh
5.8% stake
Filed 25/11/28